Business / Finance

RSS

We Care Health Services acquires Pace Group of Companies

We Care Health Services (We Care), Canada's most trusted name in home health care and support services, is pleased to announce that it is further expanding its comprehensive health care portfolio with the acquisition of the Kitchener-Waterloo based Pace Group of Companies (Pace).

12 Feb 2013

MannKind fourth quarter total operating expenses increase to $33.5 million

MannKind Corporation today reported financial results for the fourth quarter and year ended December 31, 2012.

12 Feb 2013

Skilled Healthcare fourth quarter revenue increases 2.4% to $219.2 million

Skilled Healthcare Group, Inc. today announced its consolidated financial operating results for the three and twelve-month period ended December 31, 2012.

12 Feb 2013

Omega reports operating revenues of $95.0 million for fourth quarter 2012

Omega Healthcare Investors, Inc. today announced its results of operations for the three- and twelve-month period ended December 31, 2012. The Company also reported Funds From Operations ("FFO") available to common stockholders for the three-month period ended December 31, 2012 of $61.4 million or $0.55 per common share.

12 Feb 2013

STD Med, Pavilion announce joint investment to launch Saphena Medical

Pavilion Medical Innovations L.L.C. of Norwell, MA and STD Med, Inc. of Stoughton, MA are pleased to announce a joint investment to launch Saphena Medical, Inc., a new cutting edge medical device company focused on Endoscopic Vein Harvesting technologies.

12 Feb 2013

Unilife revenues decrease to $0.7 million for three months ended December 31, 2012

Unilife Corporation, a developer and supplier of injectable drug delivery systems, today announced its financial results for the quarter ended December 31, 2012, (the second quarter of Fiscal Year 2013).

12 Feb 2013

Brookdale fourth quarter total revenue increases 4.1% to $699.7 million

Brookdale Senior Living Inc. today reported financial and operating results for the fourth quarter and full year 2012.

11 Feb 2013

Landauer reports revenue of $36.7 million for first quarter 2013

Landauer, Inc., a recognized leader in personal and environmental radiation measurement and monitoring, outsourced medical physics services and high quality medical consumable accessories, today reported financial results for its fiscal 2013 first quarter ended December 31, 2012.

11 Feb 2013

DW Healthcare Partners completes fundraising for third fund

DW Healthcare Partners, a healthcare-focused private equity firm, announced today that it has completed fundraising for its third fund, which has closed with $265 million of committed capital, exceeding its original target of $250 million.

11 Feb 2013

Decade Sunshine, 3SBio enter Merger Agreement

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it has entered into an agreement and plan of merger with Decade Sunshine Limited, an exempted company with limited liability incorporated under the laws of the Cayman Islands, and Decade Sunshine Merger Sub, an exempted company with limited liability incorporated under the laws of the Cayman Islands and a direct wholly owned subsidiary of Parent.

10 Feb 2013

KFH/HP 2012 combined total operating revenue increases to $50.6 billion

Kaiser Foundation Hospitals, Kaiser Foundation Health Plan, Inc., and their subsidiaries (KFH/HP) reported today that combined total operating revenue for 2012 was $50.6 billion, compared to $47.9 billion in 2011.

10 Feb 2013

Taro, Sun Pharma mutually agree to terminate merger agreement

Taro Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Ltd. announced today that they have mutually agreed to terminate their merger agreement, announced in August 2012, pursuant to which all shareholders of Taro would have received a cash payment of $39.50 per share upon the closing of the merger.

10 Feb 2013

CEL-SCI reports net loss of $2,310,246 for fiscal quarter ended December 31, 2012

CEL-SCI Corporation reports financial results for the fiscal quarter ended December 31, 2012.

10 Feb 2013

Care Investment Trust enters joint venture with affiliates of Calamar

Care Investment Trust Inc., a real estate investment company that invests in healthcare and seniors-related real estate, today announced that effective as of February 1, 2013, it entered into a joint venture with affiliates of Calamar Enterprises, Inc., owned 75% by affiliates of Care and 25% by affiliates of Calamar, for the acquisition of two senior apartment communities from affiliates of Calamar with an aggregate value of $23.3 million.

10 Feb 2013

Accuray announces pricing of $100 million convertible senior notes due 2018

Accuray Incorporated today announced the pricing of its offering of $100 million aggregate principal amount of 3.50% convertible senior notes due 2018.

10 Feb 2013

Neurocrine Biosciences fourth quarter net income increases to $9.5 million

Neurocrine Biosciences, Inc. today announced its financial results for the quarter and year ended December 31, 2012.

9 Feb 2013

Gilead Sciences acquires YM BioSciences

Gilead Sciences, Inc. today announced that it has completed its acquisition of YM BioSciences Inc.

9 Feb 2013

Crothall Healthcare announces acquisition of Coppell

Crothall Healthcare of Wayne, Pennsylvania, announced its acquisition of Coppell, Texas-based CREST Services, a national leader in medical equipment maintenance. The transaction was finalized on December 20, 2012.

7 Feb 2013

Lannett second quarter net sales increase 32% to $36.6 million

Lannett Company, Inc. today reported continued strong momentum, with sharply improved financial results for its fiscal 2013 second quarter ended December 31, 2012, compared with the prior year period.

7 Feb 2013

Misonix revenue increases 19% to $8.0M for six months ended December 31, 2012

Misonix, Inc., a surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for spine surgery, cranial maxillo – facial surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, today reported financial results for the six-months and the second quarter of fiscal year 2013, ended December 31, 2012.

7 Feb 2013